Explore By Subject Area   

Priming the Immune System to Provoke Checkpoints and Maintain the Immunotherapy Momentum

Dr Elizabeth M Jaffee, Johns Hopkins University, shares data demonstrating anticancer immune responses in patients with classically immune resistant cancers, through combination therapies.

February 10, 2021
Priming the Immune System to Provoke Checkpoints and Maintain the Immunotherapy Momentum
Summary:

In this webinar, you will see Dr Elizabeth M Jaffee, Johns Hopkins University, present data from studies of vaccine plus immune checkpoint combination therapy demonstrating the ability to activate anticancer immune responses in classically resistant cancers, from the 2021 Immuno-Oncology 360° Conference.

To learn more about the Immuno-Oncology 360° Conference, please visit IO360Summit.com.

Speakers

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.